In its June 2025 update, the FTSE All World Index revealed important shifts that...
Broker Prices MEDEZE at THB8.60 as Trend for Stem Cell Boost Growth Outlook
Analysts at Daol Securities (Thailand) maintain a "Buy" recommendation for MEDEZE Group Plc. (SET:...
MEDEZE to Launch ATMPs Sandbox Bang Rak, Setting Modern Medical Innovation in Thailand
Dr. Veerapol Khemarangsan, CEO of MEDEZE Group Public Company Limited (SET: MEDEZE), announced that...
Medeze Pioneers Thailand’s Leap into Advanced Medicinal Therapies with Government-Backed Sandbox
The Ministry of Public Health, through its Office of the Permanent Secretary and Vachira...
Southeast Asia Stem Cell Leader Medeze Launches Partial Offer for 10% Stake in SGX-listed Cordlife Group
Offer price of S$0.25 per share is at an attractive premium of 61.3% over...
MEDEZE Surges 4% following Robust Gain in Q1 and Potential Partnership with Singapore’s Cordlife Group
On Tuesday at 2:04 PM (Bangkok time), the share price of MEDEZE Group Public...